Literature DB >> 26796911

Implementation and evaluation of a gravimetric i.v. workflow software system in an oncology ambulatory care pharmacy.

Kelley M Reece1, Miguel A Lozano2, Ryan Roux1, Susan M Spivey1.   

Abstract

PURPOSE: The implementation and evaluation of a gravimetric i.v. workflow software system in an oncology ambulatory care pharmacy are described.
SUMMARY: To estimate the risk involved in the sterile i.v. compounding process, a failure modes and effects analysis (FMEA) in the oncology ambulatory care pharmacy was performed. When a volumetric-based process was used to reconstitute vials, the actual concentration was unknown since an assumption must be made that the exact volume of diluent was used when reconstituting the drug. This gap in our process was discovered during the FMEA and was resolved with the implementation of an i.v. workflow software solution. The i.v. software system standardized preparation steps and documented each process step, enabling a systematic review of the metrics for safety, productivity, and drug waste. Over the study period, 15,843 doses were prepared utilizing the new technology, with a total of 1,126 errors (7%) detected by the workflow software during dose preparation. Barcode scanning detected 292 (26%) of the total errors, the gravimetric weighing step detected 797 (71%) deviation errors, and 37 (3%) errors were detected at the vial reconstitution step. All errors were detected during compounding, eliminating the need to correct errors after production. Technician production time decreased by 34%, and pharmacist checking time decreased by 37%.
CONCLUSION: Implementation of a gravimetric-based software system that used barcode verification and real-time alerts improved the detection of errors in the chemotherapy preparation process when compared with self-reporting. Standardized workflow processes and the elimination of time-consuming manual steps increased productivity while vial management decreased costs.
Copyright © 2016 by the American Society of Health-System Pharmacists, Inc. All rights reserved.

Mesh:

Substances:

Year:  2016        PMID: 26796911     DOI: 10.2146/ajhp150169

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  7 in total

1.  Critical Evaluation of Pharmacy Automation and Robotic Systems: A Call to Action.

Authors:  Anthony M Boyd; Bruce W Chaffee
Journal:  Hosp Pharm       Date:  2018-07-09

Review 2.  Automated compounding technology and workflow solutions for the preparation of chemotherapy: a systematic review.

Authors:  Sarah Batson; Stephen A Mitchell; Davina Lau; Michela Canobbio; Anna de Goede; Inderjit Singh; Ulrich Loesch
Journal:  Eur J Hosp Pharm       Date:  2019-08-21

3.  Advanced Medical Devices for Preparation and Administration of Chemotherapeutic Agents: Results from a Multi-Dimensional Evaluation.

Authors:  Lucrezia Ferrario; Fabrizio Schettini; Elisabetta Garagiola; Adriana Cecchi; Lucia Lugoboni; Paolo Serra; Emanuele Porazzi; Emanuela Foglia
Journal:  Clinicoecon Outcomes Res       Date:  2020-12-01

Review 4.  Systematic evidence review of rates and burden of harm of intravenous admixture drug preparation errors in healthcare settings.

Authors:  Nancy Hedlund; Idal Beer; Torsten Hoppe-Tichy; Patricia Trbovich
Journal:  BMJ Open       Date:  2017-12-28       Impact factor: 2.692

5.  Intravenous Chemotherapy Compounding Errors in a Follow-Up Pan-Canadian Observational Study.

Authors:  Rachel E Gilbert; Melissa C Kozak; Roxanne B Dobish; Venetia C Bourrier; Paul M Koke; Vishal Kukreti; Heather A Logan; Anthony C Easty; Patricia L Trbovich
Journal:  J Oncol Pract       Date:  2018-04-20       Impact factor: 3.840

6.  Systemic Defenses to Prevent Intravenous Medication Errors in Hospitals: A Systematic Review.

Authors:  Sini Karoliina Kuitunen; Ilona Niittynen; Marja Airaksinen; Anna-Riia Holmström
Journal:  J Patient Saf       Date:  2021-12-01       Impact factor: 2.243

7.  Impact of technology-assisted versus manual sterile compounding on safety and efficiency in a Canadian community hospital.

Authors:  Mark Fan; Danny Yang; Becky Ng; Jocelyn Jackson; Katherine Bouris; Sharon Eng; Edith Rolko; Patricia Trbovich
Journal:  Am J Health Syst Pharm       Date:  2022-09-22       Impact factor: 2.980

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.